Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEMOSTOP: Misoprostol for Second-line Treatment of Post-partum Haemorrhage
NCT01116050Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Jan 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of misoprostol in postpartum hemorrhage (PPH), sponsored by CHU Caen Normandie. Started Jan 2004; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01116050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116050.